Cargando…
Low-dose naltrexone reduced anxiety in persons with multiple sclerosis during the COVID-19 pandemic
Persons with multiple sclerosis (PwMS) have been considered at high risk for vaccination and/or acquisition of COVID-19 related to their reduced immune systems and daily regimen of immune suppressing therapy. Substantiated and unsubstantiated reports on these unknown circumstances increased anxiety...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643313/ https://www.ncbi.nlm.nih.gov/pubmed/36379151 http://dx.doi.org/10.1016/j.intimp.2022.109438 |